Hiba Junaid, Data Scientist at Barts Life Sciences and Suthesh Sivapalaratnam, Consultant Haematologist at Barts Health, spoke at the Barts Health flagship event celebrating International Clinical Trials Day and its contribution to detecting rare diseases through the use of AI. Rare diseases affect over 3.5 million people in the UK alone, yet it can take nearly 5 years on average...
In the UK, millions of people are affected by blood disorders. These range from common conditions like anaemia to life-threatening diseases such as leukaemia and lymphoma, with over 41,000 people diagnosed with blood cancer each year.1 Providing a fast and accurate diagnosis for these disorders is essential to ensure timely treatment and improve patient outcomes. However, the diagnosis is a...
We are celebrating International Clinical Trials Day to highlight the groundbreaking work being done across Barts Health and Queen Mary University of London. The clinical research landscape in the UK brims with opportunity and innovation, and offers significant return on investment. We spoke with Jenny Rivers, Director of Research & Development at Barts Health NHS Trust and Academy of Medical Sciences...
Small and medium-sized enterprises (SMEs) play a key role in driving forward innovation in the NHS. At Barts Life Sciences, we support SMEs and NHS teams to learn from each other and create a better understanding of barriers and opportunities. As a result, we improve outcomes for patients, save money for the NHS, and support SMEs to grow. Over the...
We are delighted to celebrate the official launch of the Academic Centre for Healthy Ageing (ACHA) – a new joint initiative between Barts Health NHS Trust and Queen Mary University of London, supported by Barts Charity. Based at Whipps Cross Hospital, ACHA will act as a hub for interdisciplinary research, community engagement, and clinical excellence focused on ageing well. It...
The healthcare landscape is undergoing a profound transformation with the integration of advanced data science and AI technologies. Leading this change is Barts Health NHS Trust, one of the largest in the UK, which has launched the Barts Health Data Platform (BHDP) in April 2025. This innovative Secure Data Environment (SDE) service provides access to over 2.5 million identified, pseudoanonymised...
The Generation Study aims to sequence the genomes of up to 100,000 newborns and screen them for over 200 rare and actionable genetic conditions to improve early diagnosis and treatment. This pioneering study, run by Genomics England in partnership with the NHS, reflects years of public consultation, drawing insights from families affected by rare conditions, members of the public, healthcare...
As we celebrate the opening of Barts Life Sciences’ second learning hub in Waltham Forest, we spoke to Andrew Attfield, Associate Director of Public Health for Barts Health NHS Trust, and Agnieszka Wrobel, Healthcare Horizons Programme Manager, who shared their candid thoughts on the urgency of engaging the local community, the pressing need to upskill the future workforce, and how these...
A new health and life sciences hub at Waltham Forest College is set to create significant career opportunities, support the local community, and strengthen healthcare services in North-East London. This innovative initiative is part of the Barts Health Futures programme and will help address NHS skills shortages while focusing on improving care for older people. The Hub, which has received...
Barts Life Sciences is located in north-east London which is home to one of the most diverse populations in Europe. This diversity enriches and enhances our ability to reduce health inequalities and improve outcomes for people in London and the world. As healthcare increasingly adopts digital technologies, it is essential that these innovations reach all populations fairly. We speak to...
Accessibility options
Translate the page